{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:44:35Z","timestamp":1769107475314,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.healun.2003.08.017","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T15:29:25Z","timestamp":1096385365000},"page":"1082-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home"],"prefix":"10.1016","volume":"23","author":[{"given":"Susan C.","family":"Brozena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Twomey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee R.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashank S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Drachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Popjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariell","family":"Jessup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2003.08.017_BIB1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE study research group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2003.08.017_BIB2","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0003-4975(00)01313-8","article-title":"Milrinone for long-term pharmacologic support of the Status I heart transplant candidates","volume":"69","author":"Canver","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2003.08.017_BIB3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0002-9149(98)00557-8","article-title":"Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure","volume":"82","author":"Cusick","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2003.08.017_BIB4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9149(97)00284-1","article-title":"Safety and clinical utility of long-term intravenous milrinone in advanced heart failure","volume":"80","author":"Mehra","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2003.08.017_BIB5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)00461-0","article-title":"Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors","volume":"84","author":"Milfred-LaForest","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2003.08.017_BIB6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0002-8703(92)90986-6","article-title":"Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire","volume":"124","author":"Rector","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2003.08.017_BIB7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9149(83)80079-4","article-title":"Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure","volume":"51","author":"Applefeld","year":"1983","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.healun.2003.08.017_BIB8","first-page":"S30","article-title":"Outpatient dobutamine for end-stage congestive heart failure","volume":"18","author":"Miller","year":"1990","journal-title":"Crit Care Med"},{"key":"10.1016\/j.healun.2003.08.017_BIB9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0002-8703(97)80012-9","article-title":"Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure","volume":"134","author":"Sindone","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2003.08.017_BIB10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0002-8703(80)90226-4","article-title":"Long-term benefit of dobutamine in patients with congestive cardiomyopathy","volume":"100","author":"Unverferth","year":"1980","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2003.08.017_BIB11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1053-2498(98)00070-9","article-title":"The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension","volume":"18","author":"Pamboukian","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.08.017_BIB12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-5273(01)00520-4","article-title":"Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol","volume":"81","author":"Lowes","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2003.08.017_BIB13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-8703(99)70107-9","article-title":"Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure","volume":"138","author":"Hatzizacharias","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2003.08.017_BIB14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2003.08.017_BIB15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1067\/mhj.2001.117606","article-title":"Inotropic therapy for heart failure","volume":"142","author":"Felher","year":"2001","journal-title":"Am Heart J"},{"issue":"suppl","key":"10.1016\/j.healun.2003.08.017_BIB16","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S1053-2498(99)00107-2","article-title":"Outpatient parenteral inotropic therapy for advanced heart failure","volume":"19","author":"Young","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.08.017_BIB17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1378\/chest.112.5.1298","article-title":"Home inotropic therapy in advanced heart failure","volume":"112","author":"Harjai","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.healun.2003.08.017_BIB18","first-page":"809","article-title":"Outpatient inotropic therapy in heart transplant candidates","volume":"17","author":"Winkel","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.08.017_BIB19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1053-2498(02)00570-3","article-title":"Morbidity and mortality of UNOS Status IB cardiac transplant candidates at home","volume":"22","author":"Lang","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.08.017_BIB20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249803004121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249803004121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:09:30Z","timestamp":1760947770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249803004121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1053249803004121"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2003.08.017","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2003.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}